Case studies of innovative medical device companies from India: barriers and enablers to development

• Published in: BMC health services research 2013-05, Vol.13 (1), p.199-199, Article 199
• Main Authors: Jarosławski, Szymon, Saberwal, Gayatri
• Format: Article
• Language: English
• Subjects: Biotechnology - organization & administration; Biotechnology industry; Capacity Building; Capital Financing; Case studies; Commerce; Consumer Product Safety - legislation & jurisprudence; Consumer Product Safety - standards; Developing countries; Diagnostic Equipment - economics; Diagnostic Equipment - standards; Health care; Health Care Sector; Humans; Imports; Independent regulatory commissions; India; Industry; Innovations; Intellectual property; International economic relations; Interviews; Interviews as Topic; LDCs; Manufacturing; Medical device industry; Medical equipment; Medical equipment and supplies industry; Medical technology; Medical test kit industry; NGOs; Nongovernmental organizations; Organizational Affiliation; Organizational Case Studies; Physiological apparatus; Product development; Product Line Management; R&D; Regulation; Regulatory approval; Research & development; Technology Transfer
• ISSN: 1472-6963; 1472-6963
• DOI: 10.1186/1472-6963-13-199

Over 75% of the medical devices used in India are imported. Often, they are costly and maladapted to low-resource settings. We have prepared case studies of six firms in Bangalore that could contribute to solving this problem. They have developed (or are developing) innovative health care products and therefore are pioneers in the Indian health care sector, better known for its reverse engineering skills. We have sought to understand what enablers and barriers they encountered. Information for the case studies was collected through semi-structured interviews. Initially, over 40 stakeholders of the diagnostics sector in India were interviewed to understand the sector. However the focus here is on the six featured companies. Further information was obtained from company material and other published resources. In all cases, product innovation has been enabled by close interaction with local medical practitioners, links to global science and technology and global regulatory requirements. The major challenges were the lack of guidance on product specifications from the national regulatory agency, paucity of institutionalized health care payers and lack of transparency and formalized Health Technology Assessment in coverage decision-making. The absence of national evidence-based guidelines and of compulsory continuous education for medical practitioners were key obstacles in accessing the poorly regulated and fragmented private market. Innovative Indian companies would benefit from a strengthened capacity and interdisciplinary work culture of the national device regulatory body, institutionalized health care payers and medical councils and associations. Continuous medical education and national medical guidelines for medical practitioners would facilitate market access for innovative products.